Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/29461
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.contributor.author | Gölcü, Ayşegül | - |
dc.contributor.author | Büyukgüngör, Orhan | - |
dc.date.accessioned | 2022-11-16T13:18:54Z | - |
dc.date.available | 2022-11-16T13:18:54Z | - |
dc.date.issued | 2013-04 | - |
dc.identifier.citation | İçsel, C. vd. (2013). "Synthesis, crystal structures, DNA binding and cytotoxicity of two novel platinum(II) complexes containing 2-(hydroxymethyl)pyridine and pyridine-2-carboxylate ligands". Bioorganic and Medicinal Chemistry Letters, 23(7), 2117-2122. | en_US |
dc.identifier.issn | 0960-894X | - |
dc.identifier.issn | 1464-3405 | - |
dc.identifier.uri | https://doi.org/10.1016/j.bmcl.2013.01.119 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0960894X13001522 | - |
dc.identifier.uri | http://hdl.handle.net/11452/29461 | - |
dc.description.abstract | Two new platinum(II) complexes, trans-[Pt(2-mpy)(2)]center dot 4H(2)O (1) and [PtCl(2-pyc)(2-hmpy)]center dot H2O (2), where 2-hmpy = 2-(hydroxymethyl)pyridine, 2-mpy = deprotonated 2-hmpy and 2-pyc = pyridine-2-carboxylate, have been synthesized and characterized by elemental analysis, IR, NMR, and X-ray crystallography. The DNA binding affinities of these complexes for Fish Sperm DNA (FS-DNA) were investigated using fluorescence, viscosity, thermal denaturation and gel electrophoresis measurements. Fluorescence analysis indicates that complex 1 binds to DNA by a single intercalative mechanism, while complex 2 exhibits two types of interactions such as intercalation and covalent binding. Gel electrophoresis assay demonstrates ability of the complexes to cleavage the supercoiled 0311322 plasmid DNA. The in vitro cytotoxicities of both complexes were preliminarily evaluated and the cytotoxicity of complex 1 against the human lung cancer cells (H1299) is similar to oxaliplatin, but higher than transplatin and carboplatin. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject | Chemistry | en_US |
dc.subject | Pt(II) complexes | en_US |
dc.subject | 2-(Hydroxymethyl)pyridine | en_US |
dc.subject | Pyridine-2-carboxylate | en_US |
dc.subject | DNA binding | en_US |
dc.subject | Cytotoxic activity | en_US |
dc.subject | In-vitro | en_US |
dc.subject | Molecular-structure | en_US |
dc.subject | Antitumor platinum | en_US |
dc.subject | 2-acetyl pyridine | en_US |
dc.subject | Pt(II) complexes | en_US |
dc.subject | Metal-complexes | en_US |
dc.subject | Palladium(II) | en_US |
dc.subject | Mode | en_US |
dc.subject | L=2-hydroxypyridine | en_US |
dc.subject | 3-hydroxypyridine | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Antineoplastic agents | en_US |
dc.subject.mesh | Binding sites | en_US |
dc.subject.mesh | Cell line, tumor | en_US |
dc.subject.mesh | Cell proliferation | en_US |
dc.subject.mesh | Crystallography, x-ray | en_US |
dc.subject.mesh | DNA | en_US |
dc.subject.mesh | Dose-response relationship, drug | en_US |
dc.subject.mesh | Drug screening assays, antitumor | en_US |
dc.subject.mesh | Fishes | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Ligands | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Models, molecular | en_US |
dc.subject.mesh | Molecular structure | en_US |
dc.subject.mesh | Organoplatinum compounds | en_US |
dc.subject.mesh | Picolinic acids | en_US |
dc.subject.mesh | Plasmids | en_US |
dc.subject.mesh | Pyridines | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Spermatozoa | en_US |
dc.subject.mesh | Structure-activity relationship | en_US |
dc.title | Synthesis, crystal structures, DNA binding and cytotoxicity of two novel platinum(II) complexes containing 2-(hydroxymethyl)pyridine and pyridine-2-carboxylate ligands | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000316642900041 | tr_TR |
dc.identifier.scopus | 2-s2.0-84875220138 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Kimya Bölümü. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı. | tr_TR |
dc.relation.bap | BAP | tr_TR |
dc.contributor.orcid | 0000-0002-2849-3332 | tr_TR |
dc.contributor.orcid | 0000-0002-2717-2430 | tr_TR |
dc.identifier.startpage | 2117 | tr_TR |
dc.identifier.endpage | 2122 | tr_TR |
dc.identifier.volume | 23 | tr_TR |
dc.identifier.issue | 7 | tr_TR |
dc.relation.journal | Bioorganic and Medicinal Chemistry Letters | en_US |
dc.contributor.buuauthor | İçsel, Ceyda | - |
dc.contributor.buuauthor | Yılmaz, Veysel Turan | - |
dc.contributor.buuauthor | Ulukaya, Engin | - |
dc.contributor.researcherid | K-5792-2018 | tr_TR |
dc.contributor.researcherid | L-7238-2018 | tr_TR |
dc.contributor.researcherid | AAI-3342-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.identifier.pubmed | 23434229 | tr_TR |
dc.subject.wos | Chemistry, medicinal | en_US |
dc.subject.wos | Chemistry, organic | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 (Chemistry, organic) | en_US |
dc.wos.quartile | Q3 (Chemistry, medicinal) | en_US |
dc.contributor.scopusid | 55551960400 | tr_TR |
dc.contributor.scopusid | 7006269202 | tr_TR |
dc.contributor.scopusid | 6602927353 | tr_TR |
dc.subject.scopus | Antineoplastic Activity; Prodrugs; Transplatin | en_US |
dc.subject.emtree | Antineoplastic agent | en_US |
dc.subject.emtree | Carboplatin | en_US |
dc.subject.emtree | DNA | en_US |
dc.subject.emtree | Oxaliplatin | en_US |
dc.subject.emtree | Platinum derivative | en_US |
dc.subject.emtree | Transplatin | en_US |
dc.subject.emtree | Animal cell | en_US |
dc.subject.emtree | Antineoplastic activity | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Binding affinity | en_US |
dc.subject.emtree | Cancer cell | en_US |
dc.subject.emtree | Crystal structure | en_US |
dc.subject.emtree | Cytotoxicity | en_US |
dc.subject.emtree | DNA binding | en_US |
dc.subject.emtree | Drug binding | en_US |
dc.subject.emtree | Drug determination | en_US |
dc.subject.emtree | Drug mechanism | en_US |
dc.subject.emtree | Drug structure | en_US |
dc.subject.emtree | Drug synthesis | en_US |
dc.subject.emtree | Fluorescence | en_US |
dc.subject.emtree | Fluorescence analysis | en_US |
dc.subject.emtree | Gel electrophoresis | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human cell | en_US |
dc.subject.emtree | In vitro study | en_US |
dc.subject.emtree | Infrared radiation | en_US |
dc.subject.emtree | Lung cancer | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Nuclear magnetic resonance | en_US |
dc.subject.emtree | Viscosity | en_US |
dc.subject.emtree | X ray crystallography | en_US |
Koleksiyonlarda Görünür: | PubMed Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.